[Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] lipid metabolism. II. Effects on the incorporation of various isotopic precursors in rat liver].
D000818:Animals; D002994:Clofibrate / Q000031:analogs & derivatives* / Q000494:pharmacology; D006949:Hyperlipidemias / Q000378:metabolism*; D000960:Hypolipidemic Agents; D008055:Lipids / Q000096:biosynthesis*; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology; D051381:Rats
D000960:Hypolipidemic Agents; D008055:Lipids; D009539:Nicotinic Acids; D002994:Clofibrate
Acción del etofibrato [2-(nicotinoiloxi)-etil-p-clorofenoxiisobuturato] sobre el metabolismo lipídico. II. Efectos sobre la incorporación de diversos precursores isotópicos en hígado de rata.